TY - JOUR
T1 - Invasive pulmonary aspergillosis associated with viral pneumonitis
AU - Dewi, Intan MW
AU - Janssen, Nico AF
AU - Rosati, Diletta
AU - Bruno, Mariolina
AU - Netea, Mihai G.
AU - Brüggemann, Roger JM
AU - Verweij, Paul E.
AU - van de Veerdonk, Frank L.
N1 - Publisher Copyright:
© 2021 The Authors
PY - 2021/8
Y1 - 2021/8
N2 - The occurrence of invasive pulmonary aspergillosis (IPA) in critically ill patients with viral pneumonitis has increasingly been reported in recent years. Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are the two most common forms of this fungal infection. These diseases cause high mortality in patients, most of whom were previously immunocompetent. The pathogenesis of IAPA and CAPA is still not fully understood, but involves viral, fungal and host factors. In this article, we discuss several aspects regarding IAPA and CAPA, including their possible pathogenesis, the use of immunotherapy, and future challenges.
AB - The occurrence of invasive pulmonary aspergillosis (IPA) in critically ill patients with viral pneumonitis has increasingly been reported in recent years. Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are the two most common forms of this fungal infection. These diseases cause high mortality in patients, most of whom were previously immunocompetent. The pathogenesis of IAPA and CAPA is still not fully understood, but involves viral, fungal and host factors. In this article, we discuss several aspects regarding IAPA and CAPA, including their possible pathogenesis, the use of immunotherapy, and future challenges.
UR - http://www.scopus.com/inward/record.url?scp=85110588385&partnerID=8YFLogxK
U2 - 10.1016/j.mib.2021.04.006
DO - 10.1016/j.mib.2021.04.006
M3 - Review article
C2 - 34034082
AN - SCOPUS:85110588385
SN - 1369-5274
VL - 62
SP - 21
EP - 27
JO - Current Opinion in Microbiology
JF - Current Opinion in Microbiology
ER -